Journal profile · ONCOLOGY
Journal of Cancer
ISSN 1837-9664 · Ivyspring International Publisher · AUSTRALIA
Journal of Cancer: CAS Zone 3 · Medicine (2025 upgraded edition); impact factor 3.38; fully open access; APC charged, amount not published; median 97 days to acceptance (110 articles, last 24 months); 271 articles in 2025; indexed in SCIE and Scopus; flagged on an early-warning list or for an indexing change: check before submitting.
Scope
Aims, scope and focus
Journal of Cancer is published by Ivyspring International Publisher and is in Zone 3 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Cancer-related molecular mechanisms research, RNA modifications and cancer and MicroRNA in disease regulation, together about 27.7% of its articles. Its main subfields are Molecular Biology and Cancer Research. (generated from OpenAlex topic counts and CAS ranking data)
Journal of Cancer is an open-access, peer-reviewed publication with a broad scope, covering all areas of cancer research. It particularly focuses on novel concepts, new methods, innovative regimens, therapeutic agents, and alternative approaches for the early detection and intervention of cancer. Supported by an esteemed international editorial board of distinguished cancer researchers, Journal of Cancer aims to facilitate the rapid publication of high-quality cancer research while ensuring a rigorous peer-review process. Types of Articles: Research Paper Short Research Communication Review Hypothesis Methods and Protocols New Instruments and Regimens
From the journal's Aims & Scope
Research area (LetPub): ONCOLOGY
Editor-in-chief Daniel DennisPublisher website
Editorial board by country: none in mainland China; most named United States 22, Japan 4, Italy 3, Taiwan, China 1, United Kingdom 1 (37 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Cancer-related molecular mechanisms researchBiochemistry, Genetics and Molecular Biology10.7%
- RNA modifications and cancerBiochemistry, Genetics and Molecular Biology9.9%
- MicroRNA in disease regulationBiochemistry, Genetics and Molecular Biology7.1%
- Ferroptosis and cancer prognosisMedicine5.6%
- Circular RNAs in diseasesBiochemistry, Genetics and Molecular Biology5.2%
- Epigenetics and DNA MethylationBiochemistry, Genetics and Molecular Biology4.8%
- Cancer Immunotherapy and BiomarkersMedicine4.3%
- Cancer, Hypoxia, and MetabolismBiochemistry, Genetics and Molecular Biology4.1%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Oncology | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Oncology | Zone 3 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Oncology | Zone 4 |
Top journal: noReview journal: no
Database indexing
SCIEScopusDOAJLetPub
Early warning / risk: CAS Early Warning Journal List: listed in the 2021 edition (medium risk); not listed in the other 5 editions.LetPub
Indexing the journal's website claims
PMCPubMedPublisher website
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 3.38LetPub ·
- Impact factor (publisher)
- 3.4Publisher website ·
- CiteScore 2026-06
- 5.6LetPub ·
- SJR 2026-06
- 0.85LetPub ·
- SNIP 2026-06
- 0.7LetPub ·
- h-index
- 42LetPub ·
- h-index
- 114OpenAlex ·
- i10-index
- 3,606OpenAlex ·
- 2-year mean citedness
- 4.44OpenAlex ·
- Self-citation rate
- 0%LetPub ·
- Share of gold OA articles
- 99.2%LetPub ·
Volume
- Articles per year
- 329LetPub ·
- Articles per year (publisher)
- 10Publisher website ·
Articles by year OpenAlex count · 5,619 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 131 | 131 | 36 |
| 2025 | 271 | 271 | 711 |
| 2024 | 539 | 539 | 3,431 |
| 2023 | 370 | 370 | 3,414 |
| 2022 | 305 | 305 | 4,610 |
| 2021 | 645 | 645 | 12,395 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
97 daysMedian, submission to acceptance · P25–P75 70 days – 122 days
- Acceptance to online
- median 18 days (110 articles)
- Submission to online
- median 116 days
- Sample
- 110 articles with submission and acceptance dates (541 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 12 weeksLetPub ·
- Submission to publication (journal-reported)
- about 12 weeksDOAJ ·
- Peer review
- Single anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessDOAJ
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | AUD 4,000 | No | CC BY | |
| OpenAlex | AUD 2,000 | — | — | |
| LetPub | AUD 2,000 | No | — | |
| Publisher website | AUD 4,000 | — | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare4 items from the author guidelines
- Keywords
- ≥ 3
- Manuscript length
- ≤ 2,500 words
- Cover letter
- Required
- Not considered
- case reports; case series; case reviews
Article types accepted3
- research paperJournal of Cancer welcomes submissions of research papers, reviews, and short research communications in all cancer-related fields.Length not stated
- reviewManuscripts that are deemed to be of insufficient quality or unlikely to be competitive for publication are rejected during the initial screening. Remaining man…Length not stated
- short research communicationJournal of Cancer welcomes submissions of research papers, reviews, and short research communications in all cancer-related fields.Length not stated
Policy excerpts from the journal's websiteAuthorship, Conflicts of interest, Data availability, Publication ethics, License & copyright, Plagiarism, Self-archiving
- Authorship Authorship
Each author listed on a manuscript submitted to this journal must adhere to the four authorship criteria set by the International Committee of Medical Journal Editors (ICMJE): Substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data for the work; AND Drafting the work or revising it critically for important intellectual content; AND…
Source ↗Publisher website ·- Conflicts of interest Competing Interests
Competing interests (also known as "conflicts of interest") that may influence the objective presentation of research findings should be disclosed in a paragraph titled "Competing Interests," placed after the Acknowledgments section and before the References. According to the International Committee of Medical Journal Editors, financial relationships—such as employment, consultancies, stock owners…
Source ↗Publisher website ·- Data availability Data Availability
Authors are recommended to deposit large datasets in a public repository. Smaller datasets may be published as supplementary materials. Authors may provide the following: The location and method for accessing the data. If all data are included in the manuscript or supplementary materials, please specify. If the data will be shared upon request, provide detailed contact information. If the data are…
Source ↗Publisher website ·- Publication ethics Publication Ethics
Follows COPE guidelines. Model summary
Our journals follow the guidelines set by the Committee on Publication Ethics (COPE) for addressing publication ethics issues. For more details, please visit our dedicated Publication Ethics page.
Source ↗Publisher website ·- License & copyright License
Unless otherwise stated in the individual article, articles published on or after June 10, 2019 are distributed under the Creative Commons Attribution 4.0 International Licence (CC BY 4.0), subject to these Terms of Use. Authors retain copyright of their articles. Articles published before June 10, 2019 were generally distributed under the Creative Commons Attribution-NonCommercial 4.0 Internation…
Source ↗Publisher website ·- Plagiarism
Zero-tolerance plagiarism policy; screened before, during, and after publication. Model summary
Our journal upholds a zero-tolerance policy toward plagiarism, including self-plagiarism.
Source ↗Publisher website ·- Self-archiving
Permanent archiving in PubMed Central and Europe PMC. Model summary
All published articles are permanently archived by PubMed Central (U.S. National Library of Medicine) and Europe PMC.
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Ivyspring International Publisher
- Country or region
- AUSTRALIA
- Language
- English
- ISSN
- 1837-9664
- Official links
- Journal homepage ↗DOAJ
- Submission system ↗LetPub
- Author guidelines ↗LetPub
- Aims & Scope ↗LetPub
- Special issues ↗Publisher website
- APC information ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗LetPub
- Editorial board ↗LetPub
- Plagiarism policy ↗DOAJ
FAQ
Frequently asked questions about Journal of Cancer
What CAS zone is Journal of Cancer in?
In the 2025 upgraded edition of the CAS Journal Ranking, Journal of Cancer is in Zone 3 of Medicine, and in Zone 4 of the minor category Oncology. In the 2026 Xinrui edition it is in Zone 3 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Journal of Cancer?
The latest impact factor listed by LetPub is 3.38; CiteScore 5.6, h-index 114.
How long does peer review take at Journal of Cancer?
Based on the dates recorded on 110 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 97 days (interquartile range 70–122 days); authors report an average review time of about 12 weeks. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of Journal of Cancer?
According to the journal's author guidelines: Keywords: ≥ 3; Manuscript length: ≤ 2,500 words; Cover letter: Required. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of Journal of Cancer based?
Of the 37 board members whose country the journal's board page names, none are in mainland China; the countries named most often are United States (22), Japan (4) and Italy (3). Counted from the institutions listed on the board page; for reference only.
Which databases index Journal of Cancer?
According to LetPub and DOAJ records, Journal of Cancer is indexed in SCIE, Scopus and DOAJ. The journal's website also lists PMC and PubMed; that list has not been checked against each database.
Is Journal of Cancer open access, and what is the APC?
Journal of Cancer is a fully open-access journal. APC charged, amount not published.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website, DOAJ; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .